ѻý

<ѻý class="page-title">Clinical Challenges

ASCO: Lung Cancer

<ѻý class="page-description">American Society of Clinical Oncology

More in ASCO: Lung Cancer

Clinical Challenge: Low PD-L1 Expression in NSCLC

Role of single-agent pembrolizumab in low PD-L1 expression disease still in question

Jun 08, 2019
ASCO over a photo of McCormick Place in Chicago.